SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-067420
Filing Date
2023-08-15
Accepted
2023-08-15 06:11:01
Documents
43
Period of Report
2023-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183413-8k_tffpharma.htm   iXBRL 8-K 51089
2 UNDERWRITING AGREEMENT DATED AS OF AUGUST 14, 2023 BETWEEN THE COMPANY AND THE B ea183413ex1-1_tffpharma.htm EX-1.1 249339
3 OPINION OF GREENBERG TRAURIG, LLP ea183413ex5-1_tffpharma.htm EX-5.1 10675
4 PRESS RELEASE DATED AUGUST 14, 2023 REGARDING THE LAUNCH OF THE OFFERING OF COMM ea183413ex99-1_tffpharma.htm EX-99.1 7230
5 PRESS RELEASE DATED AUGUST 15, 2023 REGARDING PRICING OF THE OFFERING OF COMMON ea183413ex99-2_tffpharma.htm EX-99.2 7097
6 PRESS RELEASE DATED AUGUST 15, 2023 REGARDING THE COMPANY'S FINANCIAL RESULTS FO ea183413ex99-3_tffpharma.htm EX-99.3 68837
7 THE COMPANY'S CORPORATE UPDATE AND PRESENTATION MATERIALS ea183413ex99-4_tffpharma.htm EX-99.4 34472
8 GRAPHIC ex99-4_001.jpg GRAPHIC 482933
9 GRAPHIC ex99-4_002.jpg GRAPHIC 365389
10 GRAPHIC ex99-4_003.jpg GRAPHIC 296513
11 GRAPHIC ex99-4_004.jpg GRAPHIC 195150
12 GRAPHIC ex99-4_005.jpg GRAPHIC 129441
13 GRAPHIC ex99-4_006.jpg GRAPHIC 245807
14 GRAPHIC ex99-4_007.jpg GRAPHIC 115850
15 GRAPHIC ex99-4_008.jpg GRAPHIC 387860
16 GRAPHIC ex99-4_009.jpg GRAPHIC 227304
17 GRAPHIC ex99-4_010.jpg GRAPHIC 241013
18 GRAPHIC ex99-4_011.jpg GRAPHIC 304327
19 GRAPHIC ex99-4_012.jpg GRAPHIC 235475
20 GRAPHIC ex99-4_013.jpg GRAPHIC 207361
21 GRAPHIC ex99-4_014.jpg GRAPHIC 124909
22 GRAPHIC ex99-4_015.jpg GRAPHIC 165914
23 GRAPHIC ex99-4_016.jpg GRAPHIC 160372
24 GRAPHIC ex99-4_017.jpg GRAPHIC 384719
25 GRAPHIC ex99-4_018.jpg GRAPHIC 276971
26 GRAPHIC ex99-4_019.jpg GRAPHIC 196070
27 GRAPHIC ex99-4_020.jpg GRAPHIC 177913
28 GRAPHIC ex99-4_021.jpg GRAPHIC 120295
29 GRAPHIC ex99-4_022.jpg GRAPHIC 392653
30 GRAPHIC ex99-4_023.jpg GRAPHIC 293897
31 GRAPHIC ex99-4_024.jpg GRAPHIC 303715
32 GRAPHIC ex99-4_025.jpg GRAPHIC 460650
  Complete submission text file 0001213900-23-067420.txt   9578582

Data Files

Seq Description Document Type Size
33 XBRL SCHEMA FILE tffp-20230814.xsd EX-101.SCH 3018
34 XBRL LABEL FILE tffp-20230814_lab.xml EX-101.LAB 34240
35 XBRL PRESENTATION FILE tffp-20230814_pre.xml EX-101.PRE 22361
37 EXTRACTED XBRL INSTANCE DOCUMENT ea183413-8k_tffpharma_htm.xml XML 3402
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39102 | Film No.: 231173141
SIC: 2834 Pharmaceutical Preparations